Protective effects of safranal on hypoxia/reoxygenation‑induced injury in H9c2 cardiac myoblasts via the PI3K/AKT/GSK3β signaling pathway

Wang,Hefei; Zheng,Bin; Che,Kaimeng; Han,Xue; Li,Li; Wang,Hongfang; Liu,Yanshuang; Shi,Jing; Sun,Shijiang

doi:10.3892/etm.2021.10836

December-2021 Volume 22 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2021 Volume 22 Issue 6

Full Size Image

Article Open Access

Protective effects of safranal on hypoxia/reoxygenation‑induced injury in H9c2 cardiac myoblasts via the PI3K/AKT/GSK3β signaling pathway

Authors:
- Hefei Wang
- Bin Zheng
- Kaimeng Che
- Xue Han
- Li Li
- Hongfang Wang
- Yanshuang Liu
- Jing Shi
- Shijiang Sun
View Affiliations / Copyright

Affiliations: Department of Traditional Chinese Medicine and Medical History Literature, School of Basic Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Traditional Chinese Medicine, School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Pharmacognosy, School of Pharmacy, Hebei Medical University, Shijiazhuang, Hebei 050200, P.R. China, Department of Diagnostics, Hebei Key Laboratory of Integrative Medicine on Liver‑Kidney Patterns, Institute of Integrative Medicine, College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Scientific Research Management, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China, Department of Hospital Management and Medical History Literature, Hebei Province Hospital of Chinese Medicine, The First Affiliated Hospital, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China

Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 1400
|
Published online on: October 1, 2021

https://doi.org/10.3892/etm.2021.10836
Expand metrics +

Abstract

Safranal (SFR), an active ingredient extracted from saffron, exhibits a protective effect on the cardiovascular system. However, the mechanism of SFR against hypoxia/reoxygenation (H/R)‑induced cardiomyocyte injury has previously not been investigated in vitro. The aim of the present study was therefore to observe the protective effects of SFR on H/R‑induced cardiomyocyte injury and to explore its mechanisms. A H/R injury model of H9c2 cardiac myoblasts was established by administering 800 µmol/l CoCl2 to H9c2 cells for 24 h and reoxygenating the cells for 4 h to induce hypoxia. H9c2 cardiac myoblasts were pretreated with SFR for 12 h to evaluate the associated protective effects. A Cell Counting Kit‑8 assay was used for cell viability detection, and the expression levels of lactate dehydrogenase (LDH), creatine kinase‑MB (CK‑MB), glutathione peroxidase (GSH‑px), catalase (CAT), superoxide dismutase (SOD), malondialdehyde (MDA) and caspase‑3, and the intracellular Ca²⁺ concentration were measured using the corresponding commercial kits. Levels of reactive oxygen species (ROS) in the cells were detected using 2,7‑dichlorodihydrofluorescein diacetate. Flow cytometry was used to determine the degree of apoptosis and the level of mitochondrial membrane potential (MMP). Moreover, the expression levels of phosphorylated (p‑)PI3K, AKT, p‑AKT, glycogen synthase kinase 3β (GSK3β), p‑GSK3β, Bcl‑2, Bax, caspase‑3 and cleaved caspase‑3 were measured using western blot analysis. Results of the present study demonstrated that the H9c2 cardiac myoblasts treated with SFR exhibited significantly improved levels of viability and significantly reduced levels of ROS, compared with the H/R group. Furthermore, compared with the H/R group, SFR treatment significantly increased the MMP levels and antioxidant enzyme levels, including CAT, SOD and GSH‑px; whereas the levels of CK‑MB, LDH, MDA and intracellular Ca²⁺ concentration were significantly decreased. Moreover, the results of the present study demonstrated that SFR significantly reduced caspase‑3, cleaved caspase‑3 and Bax protein expression levels, but upregulated the Bcl‑2 protein expression levels. SFR also increased the protein expressions of PI3K/AKT/GSK3β. In summary, the results suggested that SFR may exert a protective effect against H/R‑induced cardiomyocyte injury, which occurs in connection with the inhibition of oxidative stress and apoptosis via regulation of the PI3K/AKT/GSK3β signaling pathway.

View Figures

View References

1	Sanderson JE, Mayosi B, Yusuf S, Reddy S, Hu S, Chen Z and Timmis A: Global burden of cardiovascular disease. Heart. 93(1175)2007.PubMed/NCBI View Article : Google Scholar
2	Mahmood SS, Levy D, Vasan RS and Wang TJ: The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective. Lancet. 383:999–1008. 2014.PubMed/NCBI View Article : Google Scholar
3	Zhang G, Gao S, Li X, Zhang L, Tan H, Xu L, Chen Y, Geng Y, Lin Y, Aertker B, et al: Pharmacological postconditioning with lactic acid and hydrogen rich saline alleviates myocardial reperfusion injury in rats. Sci Rep. 5(9858)2015.PubMed/NCBI View Article : Google Scholar
4	Najib K, Boateng S, Sangodkar S, Mahmood S, Whitney H, Wang CE, Racsa P and Sanborn TA: Incidence and characteristics of patients presenting with acute myocardial infarction and non-obstructive coronary artery disease. Catheter Cardiovasc Interv. 86 (Suppl 1):S23–S27. 2015.PubMed/NCBI View Article : Google Scholar
5	O'Neill WW, Topol EJ and Pitt B: Reperfusion therapy of acute myocardial infarction. Prog Cardiovasc Dis. 30:235–266. 1988.PubMed/NCBI View Article : Google Scholar
6	Braunwald E and Kloner RA: Myocardial reperfusion: A double-edged sword? J Clin Invest. 76:1713–1719. 1985.PubMed/NCBI View Article : Google Scholar
7	Hausenloy DJ and Yellon DM: Targeting myocardial reperfusion injury-the search continues. N Engl J Med. 373:1073–1075. 2015.PubMed/NCBI View Article : Google Scholar
8	Jennings RB: Historical perspective on the pathology of myocardial ischemia/reperfusion injury. Circ Res. 113:428–438. 2013.PubMed/NCBI View Article : Google Scholar
9	Turer AT and Hill JA: Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 106:360–368. 2010.PubMed/NCBI View Article : Google Scholar
10	Moens AL, Claeys MJ, Timmermans JP and Vrints CJ: Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol. 100:179–190. 2005.PubMed/NCBI View Article : Google Scholar
11	Cheng BC, Huang HS, Chao CM, Hsu CC, Chen CY and Chang CP: Hypothermia may attenuate ischemia/reperfusion-induced cardiomyocyte death by reducing autophagy. Int J Cardiol. 168:2064–2069. 2013.PubMed/NCBI View Article : Google Scholar
12	Reeve JL, Duffy AM, O'Brien T and Samali A: Don't lose heart - therapeutic value of apoptosis prevention in the treatment of cardiovascular disease. J Cell Mol Med. 9:609–622. 2005.PubMed/NCBI View Article : Google Scholar
13	Blebea J, Kerr JC, Padberg FT Jr and Hobson RW II: Triphenyl tetrazolium chloride as a histochemical marker of skeletal muscle ischemia and reperfusion injury. Curr Surg. 44:134–136. 1987.PubMed/NCBI
14	Heusch G: Molecular basis of cardioprotection: Signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res. 116:674–699. 2015.PubMed/NCBI View Article : Google Scholar
15	Hausenloy DJ and Yellon DM: Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res. 70:240–253. 2006.PubMed/NCBI View Article : Google Scholar
16	Ban K, Cooper AJ, Samuel S, Bhatti A, Patel M, Izumo S, Penninger JM, Backx PH, Oudit GY and Tsushima RG: Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning. Circ Res. 103:643–653. 2008.PubMed/NCBI View Article : Google Scholar
17	Zhang CM, Gao L, Zheng YJ and Yang HT: Berbamine protects the heart from ischemia/reperfusion injury by maintaining cytosolic Ca(2+) homeostasis and preventing calpain activation. Circ J. 76:1993–2002. 2012.PubMed/NCBI View Article : Google Scholar
18	Wu QL, Shen T, Ma H and Wang JK: Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3β pathway. J Surg Res. 178:563–570. 2012.PubMed/NCBI View Article : Google Scholar
19	Quintieri AM, Baldino N, Filice E, Seta L, Vitetti A, Tota B, De Cindio B, Cerra MC and Angelone T: Malvidin, a red wine polyphenol, modulates mammalian myocardial and coronary performance and protects the heart against ischemia/reperfusion injury. J Nutr Biochem. 24:1221–1231. 2013.PubMed/NCBI View Article : Google Scholar
20	Miura T and Miki T: GSK-3beta, a therapeutic target for cardiomyocyte protection. Circ J. 73:1184–1192. 2009.PubMed/NCBI View Article : Google Scholar
21	Abu-Izneid T, Rauf A, Khalil AA, Olatunde A, Khalid A, Alhumaydhi FA, Aljohani AS, Sahab Uddin M, Heydari M, Khayrullin M, et al: Nutritional and health beneficial properties of saffron (Crocus sativus L): A comprehensive review. Crit Rev Food Sci Nutr. 17:1–24. 2020.PubMed/NCBI View Article : Google Scholar
22	Arzi L and Hoshyar R: Saffron anti-metastatic properties, ancient spice novel application. Crit Rev Food Sci Nutr. 3:1–12. 2021.PubMed/NCBI View Article : Google Scholar
23	Maggi MA, Bisti S and Picco C: Saffron: Chemical composition and neuroprotective activity. Molecules. 25(5618)2020.PubMed/NCBI View Article : Google Scholar
24	Su X, Yuan C, Wang L, Chen R, Li X, Zhang Y, Liu C, Liu X, Liang W and Xing Y: The beneficial effects of saffron extract on potential oxidative stress in cardiovascular diseases. Oxid Med Cell Longev. 2021(6699821)2021.PubMed/NCBI View Article : Google Scholar
25	Rameshrad M, Razavi BM and Hosseinzadeh H: Saffron and its derivatives, crocin, crocetin and safranal: A patent review. Expert Opin Ther Pat. 28:147–165. 2018.PubMed/NCBI View Article : Google Scholar
26	Cerdá-Bernad D, Valero-Cases E, Pastor JJ and Frutos MJ: Saffron bioactives crocin, crocetin and safranal: Effect on oxidative stress and mechanisms of action. Crit Rev Food Sci Nutr. 24:1–18. 2020.PubMed/NCBI View Article : Google Scholar
27	Forouzanfar F, Asadpour E, Hosseinzadeh H, Boroushaki MT, Adab A, Dastpeiman SH and Sadeghnia HR: Safranal protects against ischemia-induced PC12 cell injury through inhibiting oxidative stress and apoptosis. Naunyn Schmiedebergs Arch Pharmacol. 394:707–716. 2021.PubMed/NCBI View Article : Google Scholar
28	Lambrianidou A, Koutsougianni F, Papapostolou I and Dimas K: Recent advances on the anticancer properties of saffron (Crocus sativus L.) and its major constituents. Molecules. 26(86)2020.PubMed/NCBI View Article : Google Scholar
29	Jiang X, Li Y, Feng JL, Nik Nabil WN, Wu R, Lu Y, Liu H, Xi ZC and Xu HX: Safrana l prevents prostate cancer recurrence by blocking the re-activation of quiescent cancer cells via downregulation of S-Phase kinase-associated protein 2. Front Cell Dev Biol. 8(598620)2020.PubMed/NCBI View Article : Google Scholar
30	Jin W, Xue Y, Xue Y, Liang Y, Zhang Y, Zhang J, Chu X, Wang H and Guan S: Inhibitory effects of four active components in saffron on human ether-a-go-go-related gene (hERG) K⁺ currents. Gen Physiol Biophys. 39:491–498. 2020.PubMed/NCBI View Article : Google Scholar
31	Mehdizadeh R, Parizadeh MR, Khooei AR, Mehri S and Hosseinzadeh H: Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats. Iran J Basic Med Sci. 16:56–63. 2013.PubMed/NCBI
32	Bharti S, Golechha M, Kumari S, Siddiqui KM and Arya DS: Akt/GSK-3β/eNOS phosphorylation arbitrates safranal-induced myocardial protection against ischemia-reperfusion injury in rats. Eur J Nutr. 51:719–727. 2012.PubMed/NCBI View Article : Google Scholar
33	Xue Y, Jin W, Xue Y, Zhang Y, Wang H, Zhang Y, Guan S, Chu X and Zhang J: Safranal, an active constituent of saffron, ameliorates myocardial ischemia via reduction of oxidative stress and regulation of Ca²⁺ homeostasis. J Pharmacol Sci. 143:156–164. 2020.PubMed/NCBI View Article : Google Scholar
34	Kooy NW, Royall JA and Ischiropoulos H: Oxidation of 2',7'-dichlorofluorescin by peroxynitrite. Free Radic Res. 27:245–254. 1997.PubMed/NCBI View Article : Google Scholar
35	Sivandzade F, Bhalerao A and Cucullo L: Analysis of the mitochondrial membrane potential using the cationic JC-1 dye as a sensitive fluorescent probe. Bio Protoc. 9(e3128)2019.PubMed/NCBI View Article : Google Scholar
36	Cui H, Miao S, Esworthy T, Zhou X, Lee SJ, Liu C, Yu ZX, Fisher JP, Mohiuddin M and Zhang LG: 3D bioprinting for cardiovascular regeneration and pharmacology. Adv Drug Deliv Rev. 132:252–269. 2018.PubMed/NCBI View Article : Google Scholar
37	Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, et al: American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2020 Update: A report from the American Heart Association. Circulation. 141:e139–e596. 2020.PubMed/NCBI View Article : Google Scholar
38	Simon-Yarza T, Bataille I and Letourneur D: Cardiovascular Bio-Engineering: Current State of the Art. J Cardiovasc Transl Res. 10:180–193. 2017.PubMed/NCBI View Article : Google Scholar
39	Pang Z, Wang T, Li Y, Wang L, Yang J, Dong H and Li S: Liraglutide ameliorates COCl2-induced oxidative stress and apoptosis in H9C2 cells via regulating cell autophagy. Exp Ther Med. 19:3716–3722. 2020.PubMed/NCBI View Article : Google Scholar
40	Fang Z, Luo W and Luo Y: Protective effect of α-mangostin against CoCl₂-induced apoptosis by suppressing oxidative stress in H9C2 rat cardiomyoblasts. Mol Med Rep. 17:6697–6704. 2018.PubMed/NCBI View Article : Google Scholar
41	Yang Z, Yang C, Xiao L, Liao X, Lan A, Wang X, Guo R, Chen P, Hu C and Feng J: Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxia-induced injury in H9c2 cardiac myocytes. Int J Mol Med. 28:397–403. 2011.PubMed/NCBI View Article : Google Scholar
42	Muñoz-Sánchez J and Chánez-Cárdenas ME: The use of cobalt chloride as a chemical hypoxia model. J Appl Toxicol. 39:556–570. 2019.PubMed/NCBI View Article : Google Scholar
43	Xiao L, Lan A, Mo L, Xu W, Jiang N, Hu F, Feng J and Zhang C: Hydrogen sulfide protects PC12 cells against reactive oxygen species and extracellular signal-regulated kinase 1/2-mediated downregulation of glutamate transporter-1 expression induced by chemical hypoxia. Int J Mol Med. 30:1126–1132. 2012.PubMed/NCBI View Article : Google Scholar
44	Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W and Schultz G: Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res. 69:1476–1486. 1991.PubMed/NCBI View Article : Google Scholar
45	Goyal SN, Arora S, Sharma AK, Joshi S, Ray R, Bhatia J, Kumari S and Arya DS: Preventive effect of crocin of Crocus sativus on hemodynamic, biochemical, histopathological and ultrastuctural alterations in isoproterenol-induced cardiotoxicity in rats. Phytomedicine. 17:227–232. 2010.PubMed/NCBI View Article : Google Scholar
46	Muders F, Neubauer S, Luchner A, Fredersdorf S, Ickenstein G, Riegger GA, Horn M and Elsner D: Alterations in myocardial creatinine kinase (CK) and lactate dehydrogenase (LDH) isoenzyme-distribution in a model of left ventricular dysfunction. Eur J Heart Fail. 3:1–5. 2001.PubMed/NCBI View Article : Google Scholar
47	Amani M, Jeddi S, Ahmadiasl N, Usefzade N and Zaman J: Effect of HEMADO on level of CK-MB and LDH enzymes after ischemia/reperfusion injury in isolated rat heart. Bioimpacts. 3:101–104. 2013.PubMed/NCBI View Article : Google Scholar
48	Ding M, Li M, Zhang EM and Yang HL: FULLEROL alleviates myocardial ischemia-reperfusion injury by reducing inflammation and oxidative stress in cardiomyocytes via activating the Nrf2/HO-1 signaling pathway. Eur Rev Med Pharmacol Sci. 24:9665–9674. 2020.PubMed/NCBI View Article : Google Scholar
49	Madungwe NB, Zilberstein NF, Feng Y and Bopassa JC: Critical role of mitochondrial ROS is dependent on their site of production on the electron transport chain in ischemic heart. Am J Cardiovasc Dis. 6:93–108. 2016.PubMed/NCBI
50	Del Rio D, Stewart AJ and Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 15:316–328. 2005.PubMed/NCBI View Article : Google Scholar
51	Giordano FJ: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 115:500–508. 2005.PubMed/NCBI View Article : Google Scholar
52	Ghadrdoost B, Vafaei AA, Rashidy-Pour A, Hajisoltani R, Bandegi AR, Motamedi F, Haghighi S, Sameni HR and Pahlvan S: Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. Eur J Pharmacol. 667:222–229. 2011.PubMed/NCBI View Article : Google Scholar
53	Rahaiee S, Moini S, Hashemi M and Shojaosadati SA: Evaluation of antioxidant activities of bioactive compounds and various extracts obtained from saffron (Crocus sativus L.): A review. J Food Sci Technol. 52:1881–1888. 2015.PubMed/NCBI View Article : Google Scholar
54	Assimopoulou AN, Sinakos Z and Papageorgiou VP: Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents. Phytother Res. 19:997–1000. 2005.PubMed/NCBI View Article : Google Scholar
55	Ong SB, Samangouei P, Kalkhoran SB and Hausenloy DJ: The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury. J Mol Cell Cardiol. 78:23–34. 2015.PubMed/NCBI View Article : Google Scholar
56	Ertracht O, Malka A, Atar S and Binah O: The mitochondria as a target for cardioprotection in acute myocardial ischemia. Pharmacol Ther. 142:33–40. 2014.PubMed/NCBI View Article : Google Scholar
57	Weiss JN, Korge P, Honda HM and Ping P: Role of the mitochondrial permeability transition in myocardial disease. Circ Res. 93:292–301. 2003.PubMed/NCBI View Article : Google Scholar
58	Park SS, Zhao H, Mueller RA and Xu Z: Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol. 40:708–716. 2006.PubMed/NCBI View Article : Google Scholar
59	McCully JD, Wakiyama H, Hsieh YJ, Jones M and Levitsky S: Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 286:H1923–H1935. 2004.PubMed/NCBI View Article : Google Scholar
60	Yu P, Ma S, Dai X and Cao F: Elabela alleviates myocardial ischemia reperfusion-induced apoptosis, fibrosis and mitochondrial dysfunction through PI3K/AKT signaling. Am J Transl Res. 12:4467–4477. 2020.PubMed/NCBI
61	Tao J, Abudoukelimu M, Ma YT, Yang YN, Li XM, Chen BD, Liu F, He CH and Li HY: Secreted frizzled related protein 1 protects H9C2 cells from hypoxia/re-oxygenation injury by blocking the Wnt signaling pathway. Lipids Health Dis. 15(72)2016.PubMed/NCBI View Article : Google Scholar
62	Li HW and Xiao FY: Effect of hydrogen sulfide on cardiomyocyte apoptosis in rats with myocardial ischemia-reperfusion injury via the JNK signaling pathway. Eur Rev Med Pharmacol Sci. 24:2054–2061. 2020.PubMed/NCBI View Article : Google Scholar
63	Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM and Zhou ZN: Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res. 13:385–391. 2003.PubMed/NCBI View Article : Google Scholar
64	Jayanthi S, Deng X, Bordelon M, McCoy MT and Cadet JL: Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J. 15:1745–1752. 2001.PubMed/NCBI View Article : Google Scholar
65	Zhou T, Guo S, Wang S, Li Q and Zhang M: Protective effect of sevoflurane on myocardial ischemia-reperfusion injury in rat hearts and its impact on HIF-1α and caspase-3 expression. Exp Ther Med. 14:4307–4311. 2017.PubMed/NCBI View Article : Google Scholar
66	Wang J, Liu J, Xie L, Cai X, Ma X and Gong J: Bisoprolol, a β1 antagonist, protects myocardial cells from ischemia-reperfusion injury via PI3K/AKT/GSK3β pathway. Fundam Clin Pharmacol. 34:708–720. 2020.PubMed/NCBI View Article : Google Scholar
67	Maulik A, Davidson SM, Piotrowska I, Walker M and Yellon DM: Ischaemic preconditioning protects cardiomyocytes from anthracycline-induced toxicity via the PI3K pathway. Cardiovasc Drugs Ther. 32:245–253. 2018.PubMed/NCBI View Article : Google Scholar
68	Wu X, Kihara T, Akaike A, Niidome T and Sugimoto H: PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes. Biochem Biophys Res Commun. 393:514–518. 2010.PubMed/NCBI View Article : Google Scholar
69	Wang MY, Meng M, Yang CC, Zhang L, Li YL, Zhang L and Li L: Cornel iridoid glycoside improves cognitive impairment induced by chronic cerebral hypoperfusion via activating PI3K/Akt/GSK-3β/CREB pathway in rats. Behav Brain Res. 379(112319)2020.PubMed/NCBI View Article : Google Scholar
70	Thirunavukkarasu M, Selvaraju V, Tapias L, Sanchez JA, Palesty JA and Maulik N: Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: The role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway. J Physiol Biochem. 71:623–633. 2015.PubMed/NCBI View Article : Google Scholar
71	Wang D, Zhang X, Li D, Hao W, Meng F, Wang B, Han J and Zheng Q: Kaempferide protects against myocardial ischemia/reperfusion injury through activation of the PI3K/Akt/GSK-3beta pathway. Mediators Inflamm. 2017(5278218)2017.PubMed/NCBI View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Protective effects of safranal on hypoxia/reoxygenation‑induced injury in H9c2 cardiac myoblasts via the PI3K/AKT/GSK3β signaling pathway

This article is mentioned in:

Abstract

Related Articles